StonvexLoading…
StonvexStonvexStonvexCore line items from NHPAP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $86.28M | $342.28M | $257.80M | $171.78M |
Operating Income | $10.11M | $3.30M | $9.88M | $7.51M |
Net Income | $-4.28M | $-57.69M | $-34.88M | $-22.35M |
EPS (Diluted) | $-0.27 | $-2.51 | $-1.59 | $-1.03 |
Total Assets | $1.70B | $1.71B | $1.74B | $1.76B |
Total Liabilities | $1.10B | $1.11B | $1.11B | $1.11B |
Cash & Equivalents | $52.81M | $57.62M | $47.06M | $47.12M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 28.41M | 28.43M | 28.43M | 28.45M |